DVLRX
Price
$63.76
Change
-$0.97 (-1.50%)
Updated
Dec 17 closing price
VSIAX
Price
$88.58
Change
-$1.09 (-1.22%)
Updated
Dec 17 closing price
Ad is loading...

DVLRX vs VSIAX

Header iconDVLRX vs VSIAX Comparison
Open Charts DVLRX vs VSIAXBanner chart's image
Delaware Small Cap Value R
Price$63.76
Change-$0.97 (-1.50%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$88.58
Change-$1.09 (-1.22%)
VolumeN/A
CapitalizationN/A
DVLRX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DVLRX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVLRX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. DVLRX (4.18B). VSIAX pays higher dividends than DVLRX: VSIAX (2.01) vs DVLRX (1.15). DVLRX was incepted earlier than VSIAX: DVLRX (22 years) vs VSIAX (13 years). DVLRX is a more actively managed with annual turnover of: 27.00 vs. VSIAX (16.00). DVLRX has a lower initial minimum investment than VSIAX: DVLRX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. DVLRX (4.16). VSIAX return over 5 years is better than : 52.83 vs. DVLRX (10.57).
DVLRXVSIAXDVLRX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years13 years-
Gain YTD2.86115.03119%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.18B63B7%
Annual Yield % from dividends1.152.0157%
Returns for 1 year4.1616.2326%
Returns for 3 years-7.5020.67-36%
Returns for 5 years10.5752.8320%
Returns for 10 years24.32105.6523%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics